Recent Advances in Neuropsycho-Pharmacology. Selected Papers from the 12th Congress of the Collegium Internationale Neuro–Psychopharmacologicum, Göteborg, Sweden, 22–26 June 1980

Content: 
ADVANCES IN THE BIOSCIENCES, Page ii
Front Matter, Page iii
Copyright, Page iv
PREFACE, Page v, B. Angrist, G.D. Burrows, M. Lader, O. Lingjaerde, G. Sedvall, D. Wheatley
SIMILARITIES IN THE BEHAVIORAL EFFECTS OF d-AMPHETAMINE AND APOMORPHINE IN SELECTED MEMBERS OF A PRIMATE SOCIAL COLONY, Pages 3-12, R.F. Schlemmer Jr., J.M. Davis
EFFECTS ON BEHAVIOR OF ACUTE AND CHRONIC INTRACEREBRAL INSTILLATION OF DOPAMINE AGONISTS, Pages 13-16, E.H. Ellinwood Jr., G.G. Dougherty
NORADRENALINE, DOPAMINE AND MOOD, Pages 17-29, R.H. Belmaker, B. Lerer, R.P. Ebstein
GABA: AN IMPORTANT MODERATOR AND MEDIATOR OF DOPAMINE DEPENDENT BEHAVIOURS, Pages 31-41, J. Scheel-Krüger, G. Magelund, M. Olianas, J. Arnt, A.V. Christensen
d-AMPHETAMINE AND SCHIZOPHRENIA: BEHAVIORAL, PHARMACOLOGICAL AND PHYSIOLOGICAL EVALUATIONS, Pages 43-47, D.P. van Kammen
RELATIONSHIPS BETWEEN RESPONSES TO DOPAMINE AGONISTS, PSYCHOPATHOLOGY, NEUROLEPTIC TREATMENT RESPONSE, AND NEED FOR NEUROLEPTIC MAINTENANCE IN SCHIZOPHRENIC SUBJECTS, Pages 49-54, B. Angrist, E. Peselow, J. Rotrosen, S. Gershon
DOPAMINERGIC MECHANISMS IN AFFECTIVE ILLNESS, Pages 55-61, R.M. Post, N.R. Cutler, W.E. Bunney Jr., D.C. Jimerson
MENTAL AND BEHAVIOURAL STEREOTYPIES ELICITED BY STIMULANT DRUGS. RELATION TO THE DOPAMINE HYPOTHESIS OF SCHIZO-PHRENIA, MANIA AND DEPRESSION, Pages 63-74, A. Randrup, I. Munkvad, R. Fog
EFFECTS OF METHYLPHENIDATE ON INTERPERSONAL PERCEPTIONS, Pages 75-82, D. Janowsky, P. Clopton, L. Huey, L. Judd
SEX, PLASMA PROLACTIN AND PLASMA 3-METHOXY-4-HYDROXYPHENYLGLYCOL (MHPG) PREDICT HERITABLE D-AMPHETAMINE EXCITATION IN MAN, Pages 83-91, E.S. Gershon, J.I. Nurnberger Jr., D.C. Jimerson
DEPRESSION IN THE COMMUNITY, Pages 95-99, C. Maggini, M. Mauri, G.B. Cassano
ASSESSMENT OF DEPRESSION AND THE NON-PSYCHIATRIST, Pages 101-110, J.B. Loudon, B. Tiplady
GENERAL PRACTICE PATIENTS IN CLINICAL RESEARCH: RELEVANT ISSUES, Pages 111-117, K. Rickels, R.W. Downing, W.G. Case
A RESEARCH NETWORK OF WALLOON PSYCHIATRISTS WORKING BOTH ON IN-AND OUT-PATIENTS FOR SPECIALISTS AND GENERAL PRACTITIONERS, Pages 119-124, J. Collard, M. Ansseau
ORGANIZATION AND METHODOLOGICAL ASPECTS OF OUTPATIENT STUDIES, Pages 125-134, G. Laakmann, H. Hippius
PSYCHOPHARMACOLOGICAL ASPECTS OF ORGANIC DISEASES, Pages 135-144, D.P. Wheatley
EVALUATION OF PSYCHOTROPIC DRUGS IN GENERAL PRACTICE, Pages 145-146, G. Beaumont
INTRODUCTION, Page 149, Odd Lingjaerde
METHODOLOGICAL APPROACHES FOR THE COMPARATIVE STUDY OF PLATELET AND CNS AMINERGIC FUNCTION, Page 151, J.L. Costa
PLATELET UPTAKE OF SEROTONIN IN PATHOLOGICAL CONDITIONS, Pages 153-160, J. Tuomisto
THE KINETICS OF SEROTONIN EFFLUX FROM HUMAN BLOOD PLATELETS, AND HOW IT IS INFLUENCED BY DIFFERENT DRUGS IN VIVO AND IN VITRO, Pages 161-167, O. Lingjaerde
ACTION OF NEUROTROPIC AGENTS ON PLATELET MEMBRANE, Pages 169-178, A. Pletscher, A. Laubscher
PLATELET SHAPE CHANGE IN PATIENTS WITH PSYCHIATRIC DISORDERS AND TREATED WITH PHENOTHIAZINES, THIOXANTHINES, BUTYROPHENONES, BENZODIAZEPINES, TRICYCLIC ANTIDEPRESSANTS AND β-ADRENERGIC BLOCKING AGENTS, Pages 179-185, D.J. Boullin
HIGH AFFINITY BINDING SITES FOR [3H] IMIPRAMINE IN HUMAN BRAIN AND PLATELET: CLINICAL IMPLICATIONS, Pages 187-193, S.M. Paul, M. Rehavi, P. Skolnick, F.K. Goodwin
MONOAMINE OXIDASE ACTIVITY IN PLATELETS AS RELATED TO MONOAMINE OXIDASE ACTIVITY AND MONOAMINERGIC FUNCTION IN THE BRAIN, Pages 195-201, L. Oreland, A. Wiberg, C.J. Fowler
NEURONE SPECIFIC ENOLASE (NSE) IN HUMAN BLOOD PLATELETS: IMPLICATIONS FOR THE NEURONAL MODEL, Pages 203-211, I.C. Campbell, P.J. Marangos, D.L. Murphy, A.G.E. Pearse
PLATELET NEUROTRANSMITTER - RELATED ENZYMES IN PSYCHO - PHARMACOLOGIC STUDIES, Page 213, D.L. Murphy, D.E. Redmond Jr., N.A. Garrick, S. Lipper, S. Slater, L.F. Major, C. Risch, J.L. Costa, M. Berman, J. Madden, T. Eisler, D.B. Calne
INTRODUCTION: CLINICAL ASPECTS, Pages 217-219, M. Lader
MODULATION OF BENZODIAZEPINE RECEPTORS, Pages 221-227, C. Braestrup, M. Nielsen
INTERACTIONS OF ANXIOLYTIC DRUGS WITH BENZODIAZEPINE RECEPTORS, Pages 229-238, M. Karobath, P. Supavilai, P. Placheta, W. Sieghart
NEUROANATOMICAL ASPECTS OF ANXIETY, Page 239, J.A. Gray
ANIMAL TESTS OF ANXIETY, Pages 241-251, S.E. File
CHAIRMAN'S INTRODUCTION, Pages 255-256, G. Sedvall
MONOAMINE METABOLITES IN CEREBROSPINAL FLUID IN RELATION TO DEPRESSIVE ILLNESS, SUICIDAL BEHAVIOUR AND PERSONALITY, Pages 257-271, M. Åsberg, L. Bertilsson, E. Rydin, D. Schalling, P. Thorén, L. Träskman-Bendz
5-HTP AND LITHIUM PROPHYLAXIS IN UNI-AND BIPOLAR DEPRESSION, Page 273, H.M. van Praag, S. de Haan
CEREBROSPINAL FLUID AMINES AND PEPTIDES IN AFFECTIVE ILLNESS, Pages 275-282, R.M. Post, J.C. Ballenger, D.C. Jimerson, P.W. Gold, F.K. Goodwin, D.R. Rubinow, W.E. Bunney Jr.
CEREBROSPINAL FLUID NOREPINEPHRINE AND DOPAMINE-BETA-HYDROXYLASE IN AFFECTIVE ILLNESS AND SCHIZOPHRENIA, Pages 283-287, R.M. Post, W.E. Bunney Jr., D.P. van Kammen, P. Lerner, T.W. Uhde, F.K. Goodwin, J.C. Ballenger, C.R. Lake, D.E. Sternberg
CSF TRYPTOPHAN, 5-HIAA AND HVA IN 132 PSYCHIATRIC PATIENTS CATEGORIZED BY DIAGNOSIS AND CLINICAL STATE, Pages 289-297, J.F. Leckman, D.S. Charney, C.R. Nelson, G.R. Heninger, M.B. Bowers Jr.
RELATIONSHIPS BETWEEN ABERRANT MONOAMINE METABOLITE CONCENTRATION IN CEREBROSPINAL FLUID AND FAMILY DISPOSITION FOR PSYCHIATRIC DISORDERS IN HEALTHY AND SCHIZOPHRENIC SUBJECTS, Pages 299-305, G. Sedvall, H. Nybäck, G. Oxenstierna, F.-A. Wiesel, B. Wode-Helgodt
SUICIDE, NEUROENDOCRINE DYSFUNCTION AND CSF 5-HIAA CONCENTRATIONS IN DEPRESSION, Pages 307-313, B.J. Carroll, J.F. Greden, M. Feinberg
SPINAL FLUID GABA LEVELS IN SCHIZOPHRENIA, Pages 315-321, D.P. van Kammen, R.M. Post, W.E. Bunney Jr., D.E. Sternberg, T.A. Hare, J.C. Ballenger, S.R. Marder
PATTERNS OF URINARY PEPTIDE-PROTEIN COMPLEXES IN PATIENTS DIAGNOSED AS ANOREXIA NERVOSA, Pages 323-331, O. Trygstad, I. Foss
ENDORPHIN MEASUREMENTS IN SCHIZOPHRENIA, A PROGRESS REPORT, Pages 333-336, L.H. Lindström, G. Besev, L.-M. Gunne, R. Sjöström, L. Terenius, A. Wahlström, B. Wistedt
PHARMACOKINETICS OF TRICYCLIC ANTIDEPRESSANTS, Pages 339-350, T.R. Norman, G.D. Burrows, K.P. Maguire
NOTES ON KINETICS AND METABOLISM OF BENZODIAZEPINES, Pages 351-364, S. Garattini, S. Caccia, M. Carli, T. Mennini
PHARMACOKINETICS OF ANTIPSYCHOTIC AGENTS, Pages 365-372, G.M. Simpson, E.H. Pi
RELATIONSHIPS BETWEEN PLASMA LITHIUM LEVELS AND CLINICAL AND BIOLOGICAL RESPONSES, Pages 373-382, R.P. Hullin
PHARMACOKINETIC STUDIES OF PSYCHOTROPIC DRUGS LITHIUM: SERUM, RBC AND CSF LEVELS, Pages 383-384, P. Jacobs, G. Burrows, B. Davies
RENAL BIOPSY STUDIES OF LITHIUM, PRE-LITHIUM AND DONOR KIDNEYS, Pages 387-391, P. Kincaid-Smith, R.G. Walker, B. Holwill, G.D. Burrows, B.M. Davies
THE TREATMENT OF REFRACTORY SCHIZOPHRENIA (BLOOD LEVELS OF ANTIPSYCHOTIC AGENTS), Pages 393-398, G.M. Simpson, E.H. Pi
INDEX, Pages 399-400